U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890858) titled 'A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer' on March 18.
Brief Summary: This is a prospective study investigating whether the research on Fasudil Hydrochloride in the treatment of gene-specific ovarian cancer can be applied to predict sensitivity to immunotherapy in non-small cell lung cancer (NSCLC) and other tumors. The study plans to enroll 20 patients with A/A genotype ovarian cancer for treatment evaluation.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Ovarian Cancer
Intervention:
DRUG: Fasudil Hydrochloride
Exploring whether the study of using Explorin...